Dr. Bhaskar is skilled in the management of adult solid tumours, paediatric solid tumours, haemato-oncology cases & paediatric cancers.
He is skilled in stem cell transplant - autologous, allogenic, haplo and MUD stem cell transplant.
Dr. Bhaskar’s primary interest is in the management of breast and ovarian cancers, paediatric cancer & all types of blood cancers, vis-à-vis leukaemia, lymphoma & myeloma
His secondary interests include treating lung cancers, GI cancers, prostate cancers and kidney cancers.
He also has a keen interest in preventive oncology.

Recognition

Dr. Bhaskar has served as a principal investigator for the following clinical trials:
- RONALIC trial- a phase III randomised controlled trial going at Cancer Institute (WIA), Adyar, Chennai, related to Role of Neutropenic diet in Acute Leukemia patients During Induction Chemotherapy.
- Phase III RCT related to the role of Docetaxel and trastuzumab in HER2 positive Metastatic Breast Cancer at HCG Cancer Centre, Vishakapatnam.
- Phase III RCT related to the role of Liposomal doxorubicin in recurrent ovarian cancer and metastatic Breast cancer at HCG Cancer Centre, Vishakapatnam.
- Phase III RCT related to the role of oral etoposide with cisplatin in advanced small cell lung cancer at HCG Cancer Centre, Vishakapatnam.
He has served as a sub-principal investigator for the following clinical trials:
- Phase III RCT related to the role of Nab-paclitaxel in Metastatic Breast Cancer at HCG Cancer Centre, Vishakapatnam.
He was selected to participate at CREDO 2019 – a research, skill and protocol development workshop organised by Tata Memorial Hospital, Mumbai and presented a topic for protocol development - a phase 2 single-arm study on the efficacy of pre-emptive use of plerixafor in decreasing the morbidity of autologous stem cell transplant patients.
Dr. Bhaskar has presented posters at numerous conmferences, namely:
- ‘Retrospective data on acute promyelocytic leukaemia from tertiary care oncology centre from India’ at International Conference for Korean Society Hematology (ICKSH), Seoul, South Korea, in 2019.
- ‘Retrospective data on Rhabdomyosarcoma from tertiary care oncology centre from India’ at Society international of pediatric oncology (SIOP) Asia 2019 at Abu Dhabi, UAE.
- ‘Single Institutional treatment outcomes of Acute promyelocytic leukaemia from India’ at International Conference for Indian Society Hematology (HEMATOCON), Kochi, India, in October 2019.
- ‘Rhabdomyosarcoma in teenage and young adults’ at TYACON conference 2018 at Chennai, India.
He has secured prizes in numerous quiz competitions.

Publications

Outcomes in rhabdomyosarcoma: Experience from a tertiary cancer centre in India. Cancer Research, Statistics, and Treatment, 2(1), 4.
Paper published in university journal of Tamil Nadu MGR University on topic CRIZOTINIB in ALK/ROS1 Mutation positive advanced Non-Small Cell Lung Cancer – a single centre experience from south India.
Real-time ultrasound-guided fine-needle aspiration cytology of intra-abdominal and intrapelvic masses-synergistic approach of radiologist and cytopathologist for better cellular yield - co-author.